Hefei, China · Founded 2014 · Privately Held (backing)
Developer of the core monomer of bio-based new materials such as furandicarboxylic acid (FDCA) intended to assist in the development of a sustainable environment. Leaf Biotech is based in Hefei, China and was founded in 2014. Its last reported valuation was $199 million in Jul 2025. It has raised $42 million.
Last reported valuation
$198.6M
Oct 2026
Priced at
—
Total raised
$42.0M
Last round
—
Cap table — not yet on record
Leaf Biotech's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Leaf Biotech with a free account
·Watch Leaf Biotech: the Monday email on marks, rounds and moves
